Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Vanguard Consumer Discretionary ETF
VCR
$6.25B
| $2.02M | ﹤0.01% |
6,200
+5,000
| +417% | +$1.81M |
|
|
GRP.U
2002
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.02M | ﹤0.01% |
43,100
-500
| -1% | -$23.9K |
|
2003
RXO
RXO
$3.33B
| $2.01M | ﹤0.01% |
105,400
-211,000
| -67% | -$4.62M |
|
2004
Vanguard Total International Stock ETF
VXUS
$158B
| $2.01M | ﹤0.01% |
32,300
+20,600
| +176% | +$1.27M |
|
2005
Five Point Holdings
FPH
$371M
| $2.01M | ﹤0.01% |
375,500
+1,600
| +0.4% | +$8.43K |
|
2006
Helios Technologies
HLIO
$2.7B
| $2M | ﹤0.01% |
62,475
+38,300
| +158% | +$1.54M |
|
2007
iShares Europe ETF
IEV
$1.69B
| $2M | ﹤0.01% |
34,300
+4,300
| +14% | +$244K |
|
|
VRE
2008
DELISTED
Veris Residential
VRE
| $1.99M | ﹤0.01% |
+117,800
| New | +$1.9M |
|
|
CDTX
2009
DELISTED
Cidara Therapeutics
CDTX
| $1.99M | ﹤0.01% |
92,517
-3,100
| -3% | -$68.9K |
|
2010
Apple Hospitality REIT
APLE
$3.84B
| $1.98M | ﹤0.01% |
+153,600
| New | +$2.24M |
|
2011
NewMarket
NEU
$8.24B
| $1.98M | ﹤0.01% |
3,500
-1,600
| -31% | -$843K |
|
2012
Flexible Solutions
FSI
$63.5M
| $1.97M | ﹤0.01% |
390,645
+1,200
| +0.3% | +$6.61K |
|
|
PHLT
2013
DELISTED
Performant Healthcare Inc
PHLT
| $1.97M | ﹤0.01% |
666,363
-36,500
| -5% | -$94.6K |
|
2014
Middleby
MIDD
$6.01B
| $1.97M | ﹤0.01% |
+12,970
| New | +$2.03M |
|
2015
Kodiak Sciences
KOD
$2.84B
| $1.97M | ﹤0.01% |
702,600
+241,000
| +52% | +$1.31M |
|
2016
Hanover Insurance
THG
$8.03B
| $1.97M | ﹤0.01% |
+11,300
| New | +$1.83M |
|
2017
Vanguard Russell 1000 ETF
VONE
$8.52B
| $1.95M | ﹤0.01% |
7,700
-9,600
| -55% | -$2.57M |
|
2018
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
| $1.94M | ﹤0.01% |
21,000
+8,200
| +64% | +$755K |
|
2019
Marcus & Millichap
MMI
$1.19B
| $1.94M | ﹤0.01% |
+56,253
| New | +$2.07M |
|
2020
Zumiez
ZUMZ
$337M
| $1.94M | ﹤0.01% |
130,000
+76,189
| +142% | +$1.18M |
|
|
LSEA
2021
DELISTED
Landsea Homes
LSEA
| $1.93M | ﹤0.01% |
300,513
+19,400
| +7% | +$150K |
|
2022
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.85B
| $1.93M | ﹤0.01% |
36,200
-14,400
| -28% | -$759K |
|
|
CHMI
2023
Cherry Hill Mortgage Investment Corp
CHMI
$87.4M
| $1.93M | ﹤0.01% |
583,584
+35,800
| +7% | +$119K |
|
2024
Corsair Gaming
CRSR
$1.13B
| $1.92M | ﹤0.01% |
217,070
-36,666
| -14% | -$362K |
|
2025
Neuropace
NPCE
$486M
| $1.91M | ﹤0.01% |
155,800
+69,500
| +81% | +$870K |
|
Similar funds
Renaissance Technologies's Q1 2025 Portfolio in Review
As of Q1 2025, Renaissance Technologies held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Renaissance Technologies added most to Broadcom in Q1 2025, an estimated $513M increase.
- Renaissance Technologies's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Renaissance Technologies fully exited Nike in Q1 2025, selling an estimated $197M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Renaissance Technologies opened 456 new positions and closed 583 in Q1 2025.
- Renaissance Technologies's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.